Evolent Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc., a Delaware corporation, on June 5, 2015, covering events occurring on June 4, 2015. The filing announces the pricing of the Company's initial public offering (IPO).
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the capital raise:
- Shares Offered: 11,500,000 shares of Class A common stock.
- Offering Price: $17.00 per share.
- Over-Allotment Option: Underwriters have an option to purchase up to 1,725,000 additional shares at the IPO price, less underwriting discounts and commissions.
Material Changes
The primary material change is the transition to a public company status through the pricing of the IPO. No comparative financial period data is included in this specific filing.
Guidance, Outlook, and Risks
This filing does not contain management guidance, future outlook, risk factors, or contingencies. It strictly reports the execution of the IPO pricing event and references a press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Verify the final number of shares sold, including any exercise of the underwriters' over-allotment option.
- Review the full Prospectus (not included in this 8-K) for detailed financial statements, risk factors, and use of proceeds.
- Confirm the actual net proceeds to the Company after deducting underwriting discounts and commissions.
- Check the press release (Exhibit 99.1) for management commentary on the offering.